142935-44-2 Usage
Uses
Used in Pharmaceutical Synthesis:
3,3-diethyl-4-oxoazetidin-2-yl propionate is utilized as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structural properties allow it to serve as a building block in the creation of new drugs, contributing to the development of novel therapeutic agents.
Used in Medical Research:
In the field of medical research, 3,3-diethyl-4-oxoazetidin-2-yl propionate is explored for its potential applications, including the investigation of its pharmacological properties. Its role in the synthesis of pharmaceuticals makes it a candidate for studies aimed at understanding its interactions with biological systems and its potential therapeutic effects.
Used in Drug Development:
3,3-diethyl-4-oxoazetidin-2-yl propionate is employed in the pharmaceutical industry for drug development. Its unique structural features and potential biological activities position it as a promising candidate for the design and synthesis of innovative drugs, potentially leading to advancements in treatment options for various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 142935-44-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,2,9,3 and 5 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 142935-44:
(8*1)+(7*4)+(6*2)+(5*9)+(4*3)+(3*5)+(2*4)+(1*4)=132
132 % 10 = 2
So 142935-44-2 is a valid CAS Registry Number.
142935-44-2Relevant academic research and scientific papers
NOVEL AZETIDINONES USEFUL AS INHIBITORS OF ELASTASE
-
Page/Page column 8, (2009/05/29)
The invention is directed to novel azetidinones selected from 2-(S)-[4-(((2-(Dimethylamino)ethyl)ethylamino)carbonyl)phenoxy]-3,3-diethyl-N-[1-(R)-(4-(trifluoromethoxy)phenyl)butyl]-4-oxo-1-azetidin ecarboxamide, 2-(S)-[4-(((2-(Dimethylamino)ethyl)ethylam
Process for the preparation of chiral 4-aryloxyazetidinones
-
, (2008/06/13)
A process for preparing a single enantiomer of a 4-aryloxyazetidin-2-one derivative in optically pure form comprises reacting a hindered vinyl ester with chlorosulphonyl isocyanate; displacing the hindered acyloxy group with a phenolic derivative containi